Avalo Therapeutics (AVTX) Depreciation & Amortization (CF) (2014 - 2026)
Avalo Therapeutics posted quarterly Depreciation & Amortization (CF) of $17000.0 for Q1 2026, down 87.41% year-on-year from $135000.0 in Q1 2025, and up 6.25% on a QoQ basis from $16000.0 in Q4 2025.
Avalo Therapeutics (AVTX) has 13 years of Depreciation & Amortization (CF) data on file, last reported at $17000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 87.41% year-over-year to $17000.0; the trailing twelve-month figure through Mar 2026 stood at $226000.0 (down 16.3% YoY), and the FY2025 full-year result was $344000.0, up 103.55% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $17000.0, up from $16000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $135000.0 in Q1 2025 and bottomed at $16000.0 in Q4 2025.
- The 5-year median for Depreciation & Amortization (CF) is $35000.0 (2022), against an average of $50235.3.
- The widest annual swing landed in 2022, when Depreciation & Amortization (CF) tumbled 93.42%; it then jumped 306.06% in 2025.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $35000.0 in 2022, then climbed by 22.86% to $43000.0 in 2023, then soared by 58.14% to $68000.0 in 2024, then tumbled by 76.47% to $16000.0 in 2025, then climbed by 6.25% to $17000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $17000.0 (Q1 2026), $16000.0 (Q4 2025), and $59000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - | 17,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17,000.00 |
| Mar 31, 2026 | 17,000.00 |
| Dec 31, 2025 | 16,000.00 |
| Dec 31, 2025 | 16,000.00 |
| Sep 30, 2025 | 59,000.00 |
| Sep 30, 2025 | 59,000.00 |
| Jun 30, 2025 | 134,000.00 |
| Jun 30, 2025 | 134,000.00 |
| Mar 31, 2025 | 135,000.00 |
| Mar 31, 2025 | 135,000.00 |
| Dec 31, 2024 | 68,000.00 |
| Dec 31, 2024 | 68,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Jun 30, 2024 | 33,000.00 |
| Jun 30, 2024 | 33,000.00 |
| Mar 31, 2024 | 34,000.00 |
| Mar 31, 2024 | 34,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Sep 30, 2023 | 41,000.00 |
| Sep 30, 2023 | 41,000.00 |
| Jun 30, 2023 | 41,000.00 |
| Jun 30, 2023 | 41,000.00 |
| Mar 31, 2023 | 33,000.00 |
| Mar 31, 2023 | 33,000.00 |
| Dec 31, 2022 | 35,000.00 |
| Dec 31, 2022 | 35,000.00 |
| Sep 30, 2022 | 34,000.00 |
| Sep 30, 2022 | 34,000.00 |
| Jun 30, 2022 | 30,000.00 |
| Jun 30, 2022 | 30,000.00 |
| Mar 31, 2022 | 67,000.00 |
| Mar 31, 2022 | 67,000.00 |
| Dec 31, 2021 | 295,000.00 |
| Dec 31, 2021 | 295,000.00 |
| Sep 30, 2021 | 455,000.00 |
| Sep 30, 2021 | 455,000.00 |
| Jun 30, 2021 | 456,000.00 |
| Jun 30, 2021 | 456,000.00 |
| Mar 31, 2021 | 451,000.00 |
| Mar 31, 2021 | 451,000.00 |
| Dec 31, 2020 | 538,000.00 |
| Dec 31, 2020 | 538,000.00 |
| Sep 30, 2020 | 426,000.00 |
| Sep 30, 2020 | 426,000.00 |
| Jun 30, 2020 | 426,000.00 |
| Jun 30, 2020 | 426,000.00 |
| Mar 31, 2020 | 453,000.00 |
| Mar 31, 2020 | 453,000.00 |
| Dec 31, 2019 | 617,254.00 |
| Dec 31, 2019 | 617,254.00 |
| Sep 30, 2019 | 1.06 Mn |
| Sep 30, 2019 | 1.06 Mn |
| Jun 30, 2019 | 1.10 Mn |
| Jun 30, 2019 | 1.10 Mn |
| Mar 31, 2019 | 1.10 Mn |
| Mar 31, 2019 | 1.10 Mn |
| Dec 31, 2018 | 1.22 Mn |
| Dec 31, 2018 | 1.22 Mn |
| Sep 30, 2018 | 1.07 Mn |
| Sep 30, 2018 | 1.07 Mn |
| Jun 30, 2018 | 1.24 Mn |
| Jun 30, 2018 | 1.24 Mn |
| Mar 31, 2018 | 1.02 Mn |
| Mar 31, 2018 | 1.02 Mn |
| Dec 31, 2017 | 408,426.00 |
| Dec 31, 2017 | 408,426.00 |
| Sep 30, 2017 | 5,361.00 |
| Sep 30, 2017 | 5,361.00 |
| Jun 30, 2017 | 5,859.00 |
| Jun 30, 2017 | 5,859.00 |
| Mar 31, 2017 | 5,830.00 |
| Mar 31, 2017 | 5,830.00 |
| Dec 31, 2016 | 6,388.00 |
| Dec 31, 2016 | 6,388.00 |
| Sep 30, 2016 | 7,052.00 |
| Sep 30, 2016 | 7,052.00 |
| Jun 30, 2016 | 6,628.00 |
| Jun 30, 2016 | 6,628.00 |
| Mar 31, 2016 | 6,788.00 |
| Mar 31, 2016 | 6,788.00 |
| Dec 31, 2015 | 6,148.00 |
| Dec 31, 2015 | 6,148.00 |
| Sep 30, 2015 | 6,322.00 |
| Sep 30, 2015 | 6,322.00 |
| Jun 30, 2015 | 5,519.00 |
| Jun 30, 2015 | 5,519.00 |
| Mar 31, 2015 | 5,519.00 |
| Mar 31, 2015 | 5,519.00 |
| Dec 31, 2014 | 7,881.00 |
| Dec 31, 2014 | 7,881.00 |